S&D Co (260970) Q3 2024 earnings summary

Executive summary

• Specializes in natural and functional food ingredients, with a focus on health-promoting products and ongoing diversification into cosmetics and bio-materials.

• Maintains strong certifications (GMP, ISO, HACCP, HALAL) and holds 30 patents, supporting product competitiveness.

• No subsidiaries or affiliates; operates as a standalone entity.

Financial highlights

• 2024 Q3 revenue: ₩81.5B, down from ₩88.3B in 2023 Q3, but up from ₩73.3B in 2022 Q3.

• Operating income for 2024 Q3: ₩13.7B, up from ₩12.9B in 2023 Q3.

• Net income for 2024 Q3: ₩11.2B, compared to ₩11.9B in 2023 Q3.

• Basic EPS for 2024 Q3: ₩3,334, up from ₩2,925 in 2023 Q3.

• Gross margin improved year-over-year, with cost controls and R&D investment maintained.

Outlook and guidance

• Continues to pursue diversification into new business areas, including cosmetics and bio-materials, though no immediate revenue impact expected.

• Plans to leverage existing functional food ingredient expertise for future product launches and market expansion.